Company profile: Velano Vascular
1.1 - Company Overview
Company description
- Provider of needle-free blood draw devices that leverage existing peripheral IV lines to enhance inpatient blood collection and vascular access. Its FDA-approved PIVO devices facilitate frequent, high-quality blood draws, aiming to reduce pain, risk, preanalytical errors, needlestick injuries, IV replacements, and multiple needlesticks.
Products and services
- Inpatient Blood Collection and Vascular Access Enhancement: An inpatient-focused program reducing pain, risk, and inefficiencies by expanding peripheral IV use for frequent, high-quality blood draws and strengthening vascular access practices
- PIVO™ Needle-Free Blood Draw Device: An FDA-approved device utilizing peripheral IV lines for needle-free blood collection, reducing preanalytical errors, minimizing IV replacements, and decreasing needlestick injury risk enabling high-quality draws
- PIVO™ Pro Needle-Free Blood Draw Device: A needle-free device leveraging existing IV lines to facilitate blood collection, minimizing patient discomfort and reducing need for multiple needlesticks for repeated blood draws
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Velano Vascular
YourBio Health
HQ: United States
Website
- Description: Provider of virtually painless blood collection solutions and services, simplifying blood sampling and testing. Offers TAP Micro Select for clinical-grade sampling and TAP Micro (investigational in the US, CE marked), both using HALO Technology bladeless microneedle arrays. Provides devices and customizable kitting, fulfillment, and sample tracking for decentralized clinical trials, plus turnkey wellness testing with lab integration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full YourBio Health company profile →
SynGen
HQ: United States
Website
- Description: Provider of advanced cell separation tools and accessories for regenerative medicine workflows, inventing and commercializing single-use sterile plastic cartridge disposables mated to dedicated, highly automated electromechanical medical devices to isolate and capture stem and progenitor cells from peripheral and umbilical cord blood and bone marrow.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SynGen company profile →
Exactus
HQ: United States
Website
- Description: Provider of first-of-its-kind handheld point-of-care diagnostic devices that analyze specific markers in the blood, currently being developed for commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Exactus company profile →
Akura Medical
HQ: United States
Website
- Description: Provider of a next-generation mechanical thrombectomy platform—a low-profile system for efficient removal of mixed-morphology clots in venous thromboembolism (VTE) without crossing the clot, featuring integrated aspiration and maceration technology and real-time hemodynamic data monitoring to simplify thrombectomy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Akura Medical company profile →
Perosphere Technologies
HQ: United States
Website
- Description: Provider of specialty pharmaceutical rescue medications, identifying opportunities to apply drug delivery technology to marketed drugs to create new patent-protected medical uses or enhance safety, efficacy, or ease of use, and pursuing clinical development of its drug candidates.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Perosphere Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Velano Vascular
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Velano Vascular
2.2 - Growth funds investing in similar companies to Velano Vascular
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Velano Vascular
4.2 - Public trading comparable groups for Velano Vascular
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →